The effects of high oral magnesium supplementation on blood pressure, serum lipids and related variables in apparently healthy Japanese subjects

British Journal of Nutrition

Volumn 78, Issue 5, 1997, Pages 737-750

  Itoh, Kazue ^a   Kawasaki, Terukazu ^b   Nakamura, Motoomi ^a  

^a NAKAMURA GAKUEN UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

Hypertension; Lipids; Magnesium

Indexed keywords

ALDOSTERONE; APOLIPOPROTEIN A1; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; MAGNESIUM; PHOSPHATIDYLCHOLINE STEROL ACYLTRANSFERASE;

ADRENERGIC ACTIVITY; ADULT; ALDOSTERONE URINE LEVEL; ARTICLE; BLOOD PRESSURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; DRUG URINE LEVEL; FEMALE; HEMATOCRIT; HUMAN; LIPID BLOOD LEVEL; MALE; NATRIURESIS; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; SODIUM URINE LEVEL; SYSTOLIC BLOOD PRESSURE; URINARY EXCRETION;

ADMINISTRATION, ORAL; AGED; ALDOSTERONE; APOLIPOPROTEIN A-I; BLOOD PRESSURE; CHOLESTEROL; CHOLESTEROL, HDL; DIASTOLE; DOUBLE-BLIND METHOD; ENZYME ACTIVATION; FEMALE; HEMATOCRIT; HUMANS; LIPIDS; MAGNESIUM; MALE; MIDDLE AGED; NOREPINEPHRINE; PHOSPHATIDYLCHOLINE-STEROL O-ACYLTRANSFERASE; SODIUM;

EID: 0030775298     PISSN: 00071145     EISSN: None     Source Type: Journal    
DOI: 10.1079/BJN19970191     Document Type: Article

References (40)

1. Altura, B. M. & Altura, B. T. (1995). Role of magnesium in the pathogenesis of hypertension: relationship to its action on cardiac, vascular smooth muscle, and endothelial cells updated. In Hypertension: Pathophysiology, Diagnosis, and Management, 2nd ed., pp. 1213-1242 [J. H. Laragh and B. M. Brenner, editors]. New York: Raven Press.
2. Bussiere, L., Mazur, A., Gueux, E., Nowacki, W. & Rayssiguier, Y. (1995). Triglyceride-rich lipoproteins from magnesium-deficient rats are more susceptible to oxidation by cells and promote proliferation of cultured vascular smooth muscle cells. Magnesium Research 8, 151-158.
3. Cappuccio, F. P., Markandu, N. D., Beynon, G. W., Shore, A. C. & Sampson, B. (1985). Lack of effect of oral magnesium on high blood pressure: a double blind study. British Medical Journal 291, 235-238.
4. Cohen, L., Laor, A. & Kitzes, R. (1984). Reversible retinal vasospasm in magnesium treated hypertension despite no significant change in blood pressure. Magnesium 3, 159-163.
5. Davis, W. H., Leary, W. P., Reyes, A. J. & Olhaberry, J. V. (1984). Mono-therapy with magnesium increases abnormally low high-density lipoprotein cholesterol: a clinical assay. Current Therapeutic Research 36, 341-346.
6. Durlach, J., Durlach, V., Rayssiguier, Y., Bara, M. & Guiet-Bara, A. (1992). Magnesium and blood pressure. Clinical studies. Magnesium Research 5, 147-153.
7. Friedewald, W. T., Levy, R. I. & Fredrickson, D. S. (1972). Estimation of concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clinical Chemistry 18, 499.
8. Gueux, E., Piot, M. C., Rayssiguier, Y. & Alcindor, L. (1984). The reduction of plasma lecithin-cholesterol acyltransferase activity by acute magnesium deficiency in the rat. Journal of Nutrition 114, 1479-1483.
9. Gueux, E. & Rayssiguier, Y. (1983). The effects of magnesium deficiency on glucose stimulated insulin secretion in rats. Hormone and Metabolic Research 15, 594-597.
10. Health Promotion and Nutrition Division, Health Service Bureau, Ministry of Health and Welfare (1994). Recommended Dietary Allowance for the Japanese, 5th revision, p. 76. Tokyo: Daiichi Shuppan.
11. Henderson, D. G., Schierup, J. & Schodt, T. (1986). Effect of magnesium supplementation on blood pressure and electrolytes concentrations in hypertensive patients receiving long-term diuretic treatment. British Medical Journal 293, 664-665.
12. Itoh, K., Kawasaki, T., Yoshida, H. & Nakamura, M. (1994). Effects of oral Mg supplementation on blood pressure, serum lipids and catecholamines in healthy young subjects. Journal of Hypertension 12 Suppl. 3, S86.
13. Kesteloot, H. & Joossens, J. V. (1988). Relationship of dietary sodium, potassium, calcium, and magnesium with blood pressure; Belgian interuniversity research on nutrition and health. Hypertension 12, 594-599.
14. Kihara, M., Fuzikawa, J., Ohtaka, M., Mano, M., Nara, Y., Horie, R., Tsunematsu, T., Note, S., Fukase, M. & Yamori, Y. (1984). Interrelationships between blood pressure, sodium, potassium, serum cholesterol and protein intake in Japanese. Hypertension 6, 736-742.
15. Kisters, K., Spieker, C., Tepel, M. & Zidek, W. (1993). New data about the effects of oral physiological magnesium supplementation on several cardiovascular risk factors (lipids and blood pressure). Magnesium Research 6, 355-360.
16. Kobayashi, J. (1960). A chemical study of the average quality and characteristics of river waters in Japan. Berichte des Ohara Instituts für landwirtschaftliche Forschungen Okayama Universität 11, 313-357.
17. Lai, S., Yuanchang, T., Weiling, H., Peisheng, M. & Guanqing, H. (1989). Urinary electrolytes and blood pressure in three Yi farmer populations, China. Hypertension 13, 22-30.
18. Laurant, P., Kantelip, J. P. & Berthlot, A. (1995). Dietary magnesium supplementation modifies blood pressure and cardiovascular function in mineralocorticoid-salt hypertensive rats but not in normotensive rats. Journal of Nutrition 125, 830-841.
19. Luthringer, C., Rayssiguier, Y., Gueux, E. & Berthelet, A. (1988). Effect of moderate magnesium deficiency on serum lipids, blood pressure and cardiovascular reactivity in normotensive rats. British Journal of Nutrition 59, 243-250.
20. Mahfouz, M. M., Zhou, Q., & Kummerow, F. A. (1994). Cholesterol oxides in plasma and lipoproteins of magnesium-deficient rabbits and effects of their lipoproteins on endothelial barrier function. Magnesium Research 7, 207-222.
21. Marier, J. R. (1982). Role of environmental magnesium in cardiovascular diseases. Magnesium 1, 266-276.
22. Motoyama, T., Sano, H. & Fukuzaki, H. (1989). Oral magnesium supplementation in patients with essential hypertension. Hypertension 13, 227-232.
23. Nadler, J. L., Goodson, S. & Rude, R. K. (1987). Evidence that prostacycline mediated the vascular action of magnesium in humans. Hypertension 9, 379-383.
24. Nassir, F., Mazur, A., Giannoni, F., Gueux, E., Davidson, N. O. & Rayssiguier, Y. (1995). Magnesium deficiency modulates hepatic lipogenesis and apolipoprotein gene expression in the rat. Biochimica et Biophysica Acta 1257, 125-132.
25. Rasmussen, H. S., Aurup, P., Goldstein, K., McNair, P., Mortensen, P. B., Larsen, O. G. & Lawaetz, H. (1989). Influence of magnesium substitution therapy on blood lipid composition in patients with ischemic heart disease. Archives of Internal Medicine 149, 1050-1053.
26. Rasmussen, H. S., Aurup, P., Goransson, L., Balslov, S., Larsen, O. G. & McNair, P. (1988). Magnesium deficiency in patients with ischemic heart disease, with and without acute myocardial infarction, uncovered by an intravenous loading test. Archives of Internal Medicine 148, 329-332.
27. Rayssiguier, Y. (1984). Role of magnesium and potassium in the pathogenesis of arteriosclerosis. Magnesium 3, 226-238.
28. Rayssiguier, Y. (1986). Magnesium, lipids and vascular disease. Experimental evidence in animal models. Magnesium 5, 182-190.
29. Rayssiguier, Y., Gueux, E. & Weiser, D. (1981). Effects of magnesium deficiency on lipid metabolism in rats fed a high carbohydrate diet. Journal of Nutrition 111, 1876-1883.
30. Rayssiguier, Y., Mbega, J. D., Durlach, V., Gueux, E., Durlach, J., Giry, J., Dalle, M., Mazur, A., Laurant, P. & Berthelot, A. (1992). Magnesium and blood pressure. Animal studies. Magnesium Research 5, 139-146.
31. Saito, K., Hattori, K., Omatsu, T., Hirouchi, H., Sano, H. & Fukuzaki, H. (1988). Effects of oral magnesium on blood pressure and red cell sodium transport in patients receiving long-term thiazide diuretics for hypertension. American Journal of Hypertension 1, 71s-74s.
32. Schroeder, H. A. (1960). Relations between mortality from cardiovascular disease and treated water supplies. Journal of American Medical Association 172, 1902-1908.
33. Solajic, B. N., Stavljenic, A. & Sesto, M. (1991). Lecithin: cholesterol acyl-transferase activity in patients with acute myocardial infarction and coronary heart disease. Artery 18, 326-340.
34. Soutar, A. K., Garner, C. W., Baker, H. N., Sparrow, J. T., Jackson, R. L., Gotto, A. M. & Smith, L. K. (1975). Effect of the human plasma apolipoprotein, and phosphatidylcholine acyl donor on the activity of lecithin cholesterol acyl-transferase. Biochemie 14, 3057-3064.
35. Wester, P. O. & Dyckner, T. (1987). Magnesium and hypertension. Journal of the American College of Nutrition 6, 321-328.
36. Witteman, J. C. M., Grobee, D. E., Derkx, F. H. M., Bouillon, R., Bruijn, M., Anthony, M. & Hofman, A. (1994). Reduction of blood pressure with oral magnesium supplementation in women with mild to moderate hypertension. American Journal of Clinical Nutrition 60, 129-135.
37. Yamaguchi, Y., Kitagawa, S., Kunitomo, M. & Fujiwara, M. (1994). Preventive effects of magnesium on raised serum lipid peroxide levels and aortic cholesterol deposition in mice fed an atherogenic diet. Magnesium Research 7, 31-37.
38. Yamori, Y., Kihara, M., Nara, Y., Ohtaka, M., Horie, R., Tsunematsu, T. & Note, S. (1981). Hypertension and diet: multiple regression analysis in a Japanese farming community. Lancet 1, 1204.
39. Zemel, P. C., Zemel, M. B., Urberg, M., Douglas, F. L., Geiser, P. & Sowers, J. R. (1990). Metabolic and hemodynamic effects of magnesium supplementation in patients with essential hypertension. American Journal of Clinical Nutrition 51, 665-669.
40. Zhou, Q., Mahfouz, M. M. & Kummerow, F. A. (1994). Effect of dietary magnesium deficiency with/without cholesterol supplementation on phospholipid content in liver, plasma and erythrocytes of rabbits. Magnesium Research 7, 23-30.